Consequently, in this study, we investigated the association of the CD6/ALCAM pathway with human disease by expanding the SLE and LN patient data sets to include more than 1000 individuals from 4 ethnicities and identifying the specific cell types within LN kidneys that express CD6 and ALCAM. This evidence concerns the gene ALCAM and systemic lupus erythematosus.